SIMILAR PATTERN OF AMINO ACIDS MAPPED TO '4hjj'

List of Similar Pattern of Amino Acids

Hit pattern: 3D amino acid arrangements similar to known drug binding site

Query pattern: Residues from known binding site for annotated drug that match the hit pattern


(Click on the DrReposER ID to view details on interfaces and similar patterns of amino acids)
(Click on the view link on the last column to view superposed patterns of amino acids)
Filter list by:
DrReposER ID / Desc. Hit
PDBID
Hit
Macromolecule
Res.
Matches
Interface HETATM RMSD Dali
Z-score
Seq.
Identity (%)
View Dock
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1E7W_A_MTXA301_1
(PTERIDINE REDUCTASE)
4hjj ANTI-IL12 ANTI-IL18
DFAB HEAVY CHAIN

(Homo
sapiens)
5 / 12 ARG H  68
PRO H  43
LEU H  20
LEU H  18
ASP H  91
None
1.36A 1e7wA-4hjjH:
undetectable
1e7wA-4hjjH:
23.81
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1H8S_A_AICA1000_1
(MUTANT AL2 6E7P9G)
4hjj ANTI-IL12 ANTI-IL18
DFAB HEAVY CHAIN
ANTI-IL12 ANTI-IL18
DFAB LIGHT CHAIN

(Homo
sapiens)
7 / 12 TYR L 149
GLN L 202
PHE L 212
TRP H 158
VAL H 162
ALA H 222
TRP H 236
None
0.67A 1h8sA-4hjjL:
22.6
1h8sA-4hjjL:
36.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1I2W_A_CFXA1300_2
(BETA-LACTAMASE)
4hjj ANTI-IL12 ANTI-IL18
DFAB LIGHT CHAIN

(Homo
sapiens)
4 / 5 TYR L 254
PRO L 128
LEU L 191
THR L 123
None
1.31A 1i2wA-4hjjL:
undetectable
1i2wA-4hjjL:
23.88
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1ICT_D_T44D129_2
(TRANSTHYRETIN)
4hjj ANTI-IL12 ANTI-IL18
DFAB LIGHT CHAIN

(Homo
sapiens)
4 / 7 LEU L 249
THR L 286
SER L 276
THR L 278
None
None
GOL  L 401 (-3.3A)
None
0.74A 1ictD-4hjjL:
undetectable
1ictD-4hjjL:
18.04
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1NOD_B_H4BB902_1
(NITRIC OXIDE
SYNTHASE)
4hjj ANTI-IL12 ANTI-IL18
DFAB HEAVY CHAIN

(Homo
sapiens)
3 / 3 ARG H 100
ILE H  39
TRP H  49
None
1.04A 1nodB-4hjjH:
undetectable
1nodB-4hjjH:
22.12
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2AOJ_C_FRDC305_1
(POL POLYPROTEIN
PEPTIDE INHIBITOR)
4hjj ANTI-IL12 ANTI-IL18
DFAB LIGHT CHAIN

(Homo
sapiens)
4 / 5 LEU L 293
GLY L 242
PRO L 234
VAL L 246
None
0.83A 2aojA-4hjjL:
undetectable
2aojA-4hjjL:
15.08
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2Q8H_A_TF4A438_1
([PYRUVATE
DEHYDROGENASE
[LIPOAMIDE]] KINASE
ISOZYME 1)
4hjj ANTI-IL12 ANTI-IL18
DFAB LIGHT CHAIN

(Homo
sapiens)
5 / 6 LEU L 186
TYR L 199
ILE L 171
ILE L 188
ARG L 174
None
1.33A 2q8hA-4hjjL:
undetectable
2q8hA-4hjjL:
19.95
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3K9W_A_ACTA170_0
(PHOSPHOPANTETHEINE
ADENYLYLTRANSFERASE)
4hjj ANTI-IL12 ANTI-IL18
DFAB LIGHT CHAIN

(Homo
sapiens)
3 / 3 SER L 241
GLY L 242
THR L 243
None
0.20A 3k9wA-4hjjL:
undetectable
3k9wA-4hjjL:
23.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3KEE_B_30BB500_2
(GENOME POLYPROTEIN)
4hjj ANTI-IL12 ANTI-IL18
DFAB LIGHT CHAIN

(Homo
sapiens)
3 / 3 PHE L  71
TYR L  92
LEU L  47
None
0.80A 3keeB-4hjjL:
undetectable
3keeB-4hjjL:
20.89
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4D1Y_A_RBFA1176_1
(PUTATIVE PROTEASE I)
4hjj ANTI-IL12 ANTI-IL18
DFAB LIGHT CHAIN

(Homo
sapiens)
4 / 8 GLN L 202
TRP L 207
GLN L 203
ASN L 145
None
1.44A 4d1yA-4hjjL:
undetectable
4d1yB-4hjjL:
undetectable
4d1yA-4hjjL:
21.09
4d1yB-4hjjL:
21.09
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4D1Y_A_RBFA1176_1
(PUTATIVE PROTEASE I)
4hjj ANTI-IL12 ANTI-IL18
DFAB LIGHT CHAIN

(Homo
sapiens)
4 / 8 GLN L 203
ASN L 145
GLN L 202
TRP L 207
None
1.42A 4d1yA-4hjjL:
undetectable
4d1yB-4hjjL:
undetectable
4d1yA-4hjjL:
21.09
4d1yB-4hjjL:
21.09
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4P6X_G_HCYG900_2
(GLUCOCORTICOID
RECEPTOR)
4hjj ANTI-IL12 ANTI-IL18
DFAB HEAVY CHAIN
ANTI-IL12 ANTI-IL18
DFAB LIGHT CHAIN

(Homo
sapiens)
3 / 3 LEU H  47
MET H 106
TYR L  86
None
0.96A 4p6xG-4hjjH:
undetectable
4p6xG-4hjjH:
20.22
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4ZE1_A_X2NA602_2
(LANOSTEROL 14-ALPHA
DEMETHYLASE)
4hjj ANTI-IL12 ANTI-IL18
DFAB HEAVY CHAIN
ANTI-IL12 ANTI-IL18
DFAB LIGHT CHAIN

(Homo
sapiens)
4 / 5 TYR L  87
ILE L  21
PRO L  40
THR H 194
None
1.31A 4ze1A-4hjjL:
undetectable
4ze1A-4hjjL:
20.29
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5JSD_A_1GNA607_1
(PHIAB6 TAILSPIKE)
4hjj ANTI-IL12 ANTI-IL18
DFAB HEAVY CHAIN

(Homo
sapiens)
3 / 3 THR H 153
SER H 156
TYR H 157
None
0.74A 5jsdA-4hjjH:
undetectable
5jsdA-4hjjH:
19.15
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5JSD_B_1GNB618_1
(PHIAB6 TAILSPIKE)
4hjj ANTI-IL12 ANTI-IL18
DFAB HEAVY CHAIN

(Homo
sapiens)
3 / 3 THR H 153
SER H 156
TYR H 157
None
0.75A 5jsdB-4hjjH:
undetectable
5jsdB-4hjjH:
19.15
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5JSD_C_1GNC608_1
(PHIAB6 TAILSPIKE)
4hjj ANTI-IL12 ANTI-IL18
DFAB HEAVY CHAIN

(Homo
sapiens)
3 / 3 THR H 153
SER H 156
TYR H 157
None
0.74A 5jsdC-4hjjH:
undetectable
5jsdC-4hjjH:
19.15
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5JSE_A_1GNA608_1
(PHIAB6 TAILSPIKE)
4hjj ANTI-IL12 ANTI-IL18
DFAB HEAVY CHAIN

(Homo
sapiens)
3 / 3 THR H 153
SER H 156
TYR H 157
None
0.76A 5jseA-4hjjH:
undetectable
5jseA-4hjjH:
19.15
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5JSE_B_1GNB611_1
(PHIAB6 TAILSPIKE)
4hjj ANTI-IL12 ANTI-IL18
DFAB HEAVY CHAIN

(Homo
sapiens)
3 / 3 THR H 153
SER H 156
TYR H 157
None
0.76A 5jseB-4hjjH:
undetectable
5jseB-4hjjH:
19.15
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5JSE_C_1GNC611_1
(PHIAB6 TAILSPIKE)
4hjj ANTI-IL12 ANTI-IL18
DFAB HEAVY CHAIN

(Homo
sapiens)
3 / 3 THR H 153
SER H 156
TYR H 157
None
0.76A 5jseC-4hjjH:
2.3
5jseC-4hjjH:
19.15
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5L4E_D_EDPD402_1
(PROTON-GATED ION
CHANNEL)
4hjj ANTI-IL12 ANTI-IL18
DFAB LIGHT CHAIN

(Homo
sapiens)
4 / 8 THR L  74
SER L  63
THR L  72
SER L  65
None
1.00A 5l4eA-4hjjL:
undetectable
5l4eB-4hjjL:
undetectable
5l4eC-4hjjL:
undetectable
5l4eD-4hjjL:
undetectable
5l4eE-4hjjL:
undetectable
5l4eA-4hjjL:
21.05
5l4eB-4hjjL:
21.05
5l4eC-4hjjL:
21.05
5l4eD-4hjjL:
21.05
5l4eE-4hjjL:
21.05
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6AG0_A_ACRA608_0
(ALPHA-AMYLASE)
4hjj ANTI-IL12 ANTI-IL18
DFAB HEAVY CHAIN
ANTI-IL12 ANTI-IL18
DFAB LIGHT CHAIN

(Homo
sapiens;
Homo
sapiens)
4 / 6 PHE H 175
GLY H 160
GLN L 202
TYR L 149
None
0.98A 6ag0A-4hjjH:
undetectable
6ag0A-4hjjH:
12.76
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6AG0_C_ACRC606_0
(ALPHA-AMYLASE)
4hjj ANTI-IL12 ANTI-IL18
DFAB HEAVY CHAIN
ANTI-IL12 ANTI-IL18
DFAB LIGHT CHAIN

(Homo
sapiens;
Homo
sapiens)
4 / 6 PHE H 175
GLY H 160
GLN L 202
TYR L 149
None
0.98A 6ag0C-4hjjH:
undetectable
6ag0C-4hjjH:
12.76
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6GTQ_B_ACTB207_0
(DUF1778
DOMAIN-CONTAINING
PROTEIN
N-ACETYLTRANSFERASE)
4hjj ANTI-IL12 ANTI-IL18
DFAB HEAVY CHAIN
ANTI-IL12 ANTI-IL18
DFAB LIGHT CHAIN

(Homo
sapiens;
Homo
sapiens)
4 / 6 LEU L 159
THR H 232
GLY H 225
ARG H 223
None
1.28A 6gtqB-4hjjL:
undetectable
6gtqD-4hjjL:
undetectable
6gtqB-4hjjL:
19.15
6gtqD-4hjjL:
8.92